164 related articles for article (PubMed ID: 37788720)
1. An enterovirus A71 virus-like particle with replaced loops confers partial cross-protection in mice.
Liu X; Zhu H; Wang M; Zhang N; Wang J; Tan W; Wu G; Yu P; Liu H; Liu Q
Virus Res; 2023 Nov; 337():199235. PubMed ID: 37788720
[TBL] [Abstract][Full Text] [Related]
2. Immunological and biochemical characterizations of coxsackievirus A6 and A10 viral particles.
Liu CC; Guo MS; Wu SR; Lin HY; Yang YT; Liu WC; Chow YH; Shieh DB; Wang JR; Chong P
Antiviral Res; 2016 May; 129():58-66. PubMed ID: 26899790
[TBL] [Abstract][Full Text] [Related]
3. Substitution of Coxsackievirus A16 VP1 BC and EF Loop Altered the Protective Immune Responses in Chimera Enterovirus A71.
Tan XH; Chong WL; Lee VS; Abdullah S; Jasni K; Suarni SQ; Perera D; Sam IC; Chan YF
Vaccines (Basel); 2023 Aug; 11(8):. PubMed ID: 37631931
[TBL] [Abstract][Full Text] [Related]
4. The epidemiological characteristics of enterovirus infection before and after the use of enterovirus 71 inactivated vaccine in Kunming, China.
Jiang H; Zhang Z; Rao Q; Wang X; Wang M; Du T; Tang J; Long S; Zhang J; Luo J; Pan Y; Chen J; Ma J; Liu X; Fan M; Zhang T; Sun Q
Emerg Microbes Infect; 2021 Dec; 10(1):619-628. PubMed ID: 33682641
[TBL] [Abstract][Full Text] [Related]
5. Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease.
Lyu K; He YL; Li HY; Chen R
J Virol; 2015 Jun; 89(12):6196-208. PubMed ID: 25833050
[TBL] [Abstract][Full Text] [Related]
6. Is a multivalent hand, foot, and mouth disease vaccine feasible?
Klein M; Chong P
Hum Vaccin Immunother; 2015; 11(11):2688-704. PubMed ID: 26009802
[TBL] [Abstract][Full Text] [Related]
7. Molecular epidemiology and clinical features of hand, foot and mouth disease requiring hospitalization after the use of enterovirus A71 inactivated vaccine in chengdu, China, 2017-2022: a descriptive study.
Duan X; Zhang C; Wang X; Ren X; Peng H; Tang X; Zhang L; Chen Z; Ye Y; Zheng M; Zhong W; Chen X; Zeng Y; Yuan P; Long L
Emerg Microbes Infect; 2022 Dec; 11(1):2510-2519. PubMed ID: 36103331
[TBL] [Abstract][Full Text] [Related]
8. EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases.
Mao Q; Wang Y; Bian L; Xu M; Liang Z
Emerg Microbes Infect; 2016 Jul; 5(7):e75. PubMed ID: 27436364
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and performance of an enterovirus 71 virus-like-particle vaccine in nonhuman primates.
Lim PY; Hickey AC; Jamiluddin MF; Hamid S; Kramer J; Santos R; Bossart KN; Cardosa MJ
Vaccine; 2015 Nov; 33(44):6017-24. PubMed ID: 26271825
[TBL] [Abstract][Full Text] [Related]
10. Hand, Foot, and Mouth Disease in China: Modeling Epidemic Dynamics of Enterovirus Serotypes and Implications for Vaccination.
Takahashi S; Liao Q; Van Boeckel TP; Xing W; Sun J; Hsiao VY; Metcalf CJ; Chang Z; Liu F; Zhang J; Wu JT; Cowling BJ; Leung GM; Farrar JJ; van Doorn HR; Grenfell BT; Yu H
PLoS Med; 2016 Feb; 13(2):e1001958. PubMed ID: 26882540
[TBL] [Abstract][Full Text] [Related]
11. Novel recombinant chimeric virus-like particle is immunogenic and protective against both enterovirus 71 and coxsackievirus A16 in mice.
Zhao H; Li HY; Han JF; Deng YQ; Zhu SY; Li XF; Yang HQ; Li YX; Zhang Y; Qin ED; Chen R; Qin CF
Sci Rep; 2015 Jan; 5():7878. PubMed ID: 25597595
[TBL] [Abstract][Full Text] [Related]
12. Safety and immunogenicity of an experimental live combination vaccine against enterovirus 71 and coxsackievirus A16 in rhesus monkeys.
Yang T; Xie T; Song X; Shen D; Li H; Yue L; Jiang Q; Zhu F; Meng H; Long R; Yang R; Luo F; Xie Z
Hum Vaccin Immunother; 2020 Jul; 16(7):1586-1594. PubMed ID: 32159429
[TBL] [Abstract][Full Text] [Related]
13. [Pathogen spectrum in enteroviral infections among children in Beijing from 2010 to 2016].
Yu FY; Zhu RN; Deng J; Song QW; Jia LP; Liu LY; Qian Y
Zhonghua Er Ke Za Zhi; 2018 Aug; 56(8):575-581. PubMed ID: 30078237
[No Abstract] [Full Text] [Related]
14. Coxsackieviruses A6 and A16 associated with hand, foot, and mouth disease in Vietnam, 2008-2017: Essential information for rational vaccine design.
Hoa-Tran TN; Dao ATH; Nguyen AT; Kataoka C; Takemura T; Pham CH; Vu HM; Hong TTT; Ha NTV; Duong TN; Thanh NTH; Shimizu H
Vaccine; 2020 Dec; 38(52):8273-8285. PubMed ID: 33223308
[TBL] [Abstract][Full Text] [Related]
15. The spatial-temporal distribution and etiological characteristics of hand-foot-and-mouth disease before and after EV‑A71 vaccination in Kunming, China, 2017-2020.
Wang M; Chen T; Peng J; Luo Y; Du L; Lu Z; He J; Liu C; Gan Q; Ma W; Cun Z; Zheng Q; Chen W; Chen Y; Han M; Liu G; Li J
Sci Rep; 2022 Oct; 12(1):17028. PubMed ID: 36220850
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal study on enterovirus A71 and coxsackievirus A16 genotype/subgenotype replacements in hand, foot and mouth disease patients in Thailand, 2000-2017.
Noisumdaeng P; Korkusol A; Prasertsopon J; Sangsiriwut K; Chokephaibulkit K; Mungaomklang A; Thitithanyanont A; Buathong R; Guntapong R; Puthavathana P
Int J Infect Dis; 2019 Mar; 80():84-91. PubMed ID: 30639624
[TBL] [Abstract][Full Text] [Related]
17. Recent development of enterovirus A vaccine candidates for the prevention of hand, foot, and mouth disease.
Fang CY; Liu CC
Expert Rev Vaccines; 2018 Sep; 17(9):819-831. PubMed ID: 30095317
[TBL] [Abstract][Full Text] [Related]
18. Enterovirus A71 Containing Codon-Deoptimized VP1 and High-Fidelity Polymerase as Next-Generation Vaccine Candidate.
Tsai YH; Huang SW; Hsieh WS; Cheng CK; Chang CF; Wang YF; Wang JR
J Virol; 2019 Jul; 93(13):. PubMed ID: 30996087
[TBL] [Abstract][Full Text] [Related]
19. A virus-like particle-based tetravalent vaccine for hand, foot, and mouth disease elicits broad and balanced protective immunity.
Zhang W; Dai W; Zhang C; Zhou Y; Xiong P; Wang S; Ye X; Liu Q; Zhou D; Huang Z
Emerg Microbes Infect; 2018 May; 7(1):94. PubMed ID: 29777102
[TBL] [Abstract][Full Text] [Related]
20. microRNA-4516 Contributes to Different Functions of Epithelial Permeability Barrier by Targeting Poliovirus Receptor Related Protein 1 in Enterovirus 71 and Coxsackievirus A16 Infections.
Hu Y; Song J; Liu L; Zhang Y; Wang L; Li Q
Front Cell Infect Microbiol; 2018; 8():110. PubMed ID: 29686973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
